James Sapirstein
Director · Inmune Bio, Inc.
Individual
- 2025
- Sep 17, 2026
- 3
Other insiders active in the same sector
No other insider has filed at James Sapirstein's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Fairmount Funds Management LLC - $300.01M in ORKA purchases and sales in the last 12 months
- A/S Genmab - $234.86M in MRUS purchases and sales in the last 12 months
- Weiss Asset Management LP - $233.35M in AVDL purchases and sales in the last 12 months
- James Edgemond - $201.52M in UTHR purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $199.99M in TYRA purchases and sales in the last 12 months
- Catalyst4, Inc. - $191.21M in MPLT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James Sapirstein?
James Sapirstein is a corporate insider, tracked as Director of Inmune Bio, Inc. (INMB). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has James Sapirstein submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
